Ted Yednock

13.8k total citations · 1 hit paper
78 papers, 5.9k citations indexed

About

Ted Yednock is a scholar working on Immunology and Allergy, Immunology and Molecular Biology. According to data from OpenAlex, Ted Yednock has authored 78 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Immunology and Allergy, 29 papers in Immunology and 16 papers in Molecular Biology. Recurrent topics in Ted Yednock's work include Cell Adhesion Molecules Research (37 papers), Monoclonal and Polyclonal Antibodies Research (16 papers) and Neuroinflammation and Neurodegeneration Mechanisms (13 papers). Ted Yednock is often cited by papers focused on Cell Adhesion Molecules Research (37 papers), Monoclonal and Polyclonal Antibodies Research (16 papers) and Neuroinflammation and Neurodegeneration Mechanisms (13 papers). Ted Yednock collaborates with scholars based in United States, Canada and United Kingdom. Ted Yednock's co-authors include Steven D. Rosen, Lawrence C. Fritz, Catherine Cannon, Francisco Sánchez‐Madrid, Lawrence Steinman, Nathan Karin, Mark S. Singer, Lloyd M. Stoolman, John Chen and Yasuyuki Taooka and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Ted Yednock

77 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin

1992 1.4k citations Ted Yednock, Francisco Sánchez‐Madrid et al. profile →

Peers

Countries citing papers authored by Ted Yednock

Since Specialization

Citations

This map shows the geographic impact of Ted Yednock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ted Yednock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ted Yednock more than expected).

Fields of papers citing papers by Ted Yednock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ted Yednock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ted Yednock. The network helps show where Ted Yednock may publish in the future.

Co-authorship network of co-authors of Ted Yednock

This figure shows the co-authorship network connecting the top 25 collaborators of Ted Yednock. A scholar is included among the top collaborators of Ted Yednock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ted Yednock. Ted Yednock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacokinetic and Target Engagement Measures of ANX007, an Anti-C1q Antibody Fragment, Following Intravitreal Administration in Nonhuman Primates 2023 ·Investigative Ophthalmology & Visual Science ·Anita Grover, Sethu Sankaranarayanan, Vidhu Mathur, (unknown), Haiyan Qiu, Yaisa Andrews‐Zwilling, (unknown), (unknown), Ellen Cahir-McFarland, Sanjay C. Keswani, Ted Yednock	8
2	Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington’s disease 2023 ·Nature Medicine ·Daniel K. Wilton, Kevin Mastro, (unknown), Frederick W. Gergits, (unknown), (unknown), Arnaud Frouin, Anthony Daggett, Xiaofeng Gu, (unknown), Richard L. M. Faull, Suman Jayadev, Ted Yednock, X. William Yang, Beth Stevens	79
3	Inhibiting C1q Improves Compound Muscle Action Potential and Reduces Neuronal Damage in the SOD1G93A Mouse Model (P1-13.004) 2022 ·Neurology ·Yaisa Andrews‐Zwilling, Vidhu Mathur, (unknown), Sethu Sankaranarayanan, Ellen Cahir-McFarland, Ted Yednock	2
4	C1q and the classical complement cascade in geographic atrophy secondary to age-related macular degeneration 2022 ·International Journal of Retina and Vitreous ·Ted Yednock, Donald S. Fong, Eleonora M. Lad	21
5	Complement factor C1q mediates sleep spindle loss and epileptic spikes after mild brain injury 2021 ·Science ·Stephanie S. Holden, Fiorella C. Grandi, (unknown), Bryan Higashikubo, Frances S. Cho, Andrew H. Chang, Alejandro Osorio-Forero, (unknown), Vidhu Mathur, (unknown), (unknown), Sethu Sankaranarayanan, Yaisa Andrews‐Zwilling, Andrea J. Tenner, Anita Lüthi, Eleonora Aronica, M. Ryan Corces, Ted Yednock, Jeanne T. Paz	73
6	Pharmacokinetics and target engagement of intravitreal administration of ANX007, an anti-C1q antibody fragment, in nonhuman primates 2021 ·Investigative Ophthalmology & Visual Science ·Anita Grover, Sethu Sankaranarayanan, Vidhu Mathur, (unknown), Yaisa Andrews‐Zwilling, (unknown), (unknown), Ellen Cahir-McFarland, Sanjay C. Keswani, Ted Yednock	2
7	C1q-targeted inhibition of the classical complement pathway prevents injury in a novel mouse model of acute motor axonal neuropathy 2016 ·Acta Neuropathologica Communications ·Rhona McGonigal, (unknown), Denggao Yao, Jennifer A. Barrie, Sethu Sankaranarayanan, Simon Ngamli Fewou, Koichi Furukawa, Ted Yednock, Hugh J. Willison	49
8	Systems-Based Analyses of Brain Regions Functionally Impacted in Parkinson's Disease Reveals Underlying Causal Mechanisms 2014 ·PLoS ONE ·Brigit E. Riley, Shyra J. Gardai, Dorothea Emig-Agius, Marina Bessarabova, Alexander E. Ivliev, (unknown), Jeff Alexander, William H. Wallace, Glenda M. Halliday, J. William Langston, (unknown), Ted Yednock, Thomas A. Shaler, Jennifer Johnston	65
9	Sustained levels of antibodies against Aβ in amyloid-rich regions of the CNS following intravenous dosing in human APP transgenic mice 2012 ·Experimental Neurology ·Frédérique Bard, Michael Fox, Stuart Friedrich, Peter Seubert, Dale Schenk, Gene G. Kinney, Ted Yednock	40
10	Anti‐JC virus antibodies: Implications for PML Risk Stratification 2010 ·Annals of Neurology ·Leonid Gorelik, Michaela Lerner, Sarah A. Bixler, Mary Crossman, Brian Schlain, Kenneth J. Simon, (unknown), Anne E. Cheung, Ling Ling Chen, Melissa Berman, (unknown), (unknown), Ted Yednock, Alfred Sandrock, Susan Goelz, Meena Subramanyam	326
11	α2β1 and αVβ1 integrin signaling pathways mediate amyloid-β-induced neurotoxicity 2006 ·Neurobiology of Aging ·Sarah Wright, Nikolay Malinin, Kyle Powell, Ted Yednock, Russell E. Rydel, Irene Griswold‐Prenner	60
12	Spontaneous remyelination following prolonged inhibition of α4 integrin in chronic EAE 2005 ·Journal of Neuroimmunology ·(unknown), Ted Yednock, Elizabeth K. Messersmith, Michael A. Pleiss, Stephen B. Freedman, Robert Hammond, Stephen J. Karlik	12
13	The Identification and Optimization of Orally Efficacious, Small Molecule VLA-4 Antagonists 2004 ·Current Topics in Medicinal Chemistry ·Donna M. Huryn, Andrei W. Konradi, Susan Ashwell, Stephen B. Freedman, Louis J. Lombardo, Michael A. Pleiss, Eugene D. Thorsett, Ted Yednock, Jeffrey D. Kennedy	26
14	The role of microglia in Alzheimer’s disease: friend or foe? 2002 ·Neurobiology of Aging ·Dale Schenk, Ted Yednock	28
15	A Role of Chondroitin Sulfate Glycosaminoglycan Binding Site in α4β1 Integrin-mediated Melanoma Cell Adhesion 1998 ·Journal of Biological Chemistry ·Joji Iida, Alexandra M.L. Meijne, Theodore R. Oegema, Ted Yednock, Nicholas L. Kovach, Leo T. Furcht, James B. McCarthy	96
16	Intracellular calcium requirements for β1 integrin activation 1998 ·Journal of Cellular Physiology ·Mark E. Rowin, Ralph E. Whatley, Ted Yednock, John F. Bohnsack	23
17	Functional Regulation of β1 Integrins on Human Eosinophils by Divalent Cations and Cytokines 1996 ·American Journal of Respiratory Cell and Molecular Biology ·S. Werfel, Ted Yednock, Kenji Matsumoto, Sherry A. Sterbinsky, Robert P. Schleimer, Bruce S. Bochner	21
18	GlyCAM-1, a physiologic ligand for L-selectin, activates beta 2 integrins on naive peripheral lymphocytes. 1996 ·The Journal of Experimental Medicine ·Sam T. Hwang, M S Singer, Patricia Giblin, Ted Yednock, Kevin B. Bacon, Scott I. Simon, Steven D. Rosen	144
19	Expression and functional significance of an activation‐dependent epitope of the β1 integrins in chronic inflammatory diseases 1995 ·European Journal of Immunology ·Alicia G. Arroyo, Rosario García‐Vicuña, Mónica Marazuela, Ted Yednock, Roberto González‐Amaro, Francisco Sánchez‐Madrid	28
20	Coordinate expression of β1 and β2 integrin “activation” epitopes during T cell responses in secondary lymphoid tissue 1993 ·European Journal of Immunology ·Louis J. Picker, (unknown), Mai Ánh Nguyễn, Leon W.M.M. Terstappen, Nancy Hogg, Ted Yednock	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact